Disseminated tuberculosis and Weight decreased

Summary:

Weight decreased is found among people with Disseminated tuberculosis, especially for people who are male, 60+ old.

The study analyzes which people have Weight decreased with Disseminated tuberculosis. It is created by eHealthMe based on reports of 11 people who have Disseminated tuberculosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Disseminated tuberculosis?

Disseminated tuberculosis is found to be associated with 182 drugs and 527 conditions by eHealthMe. Check the latest studies of Disseminated tuberculosis.

What is Weight decreased?

Weight decreased is found to be associated with 3,385 drugs and 4,751 conditions by eHealthMe. Check the latest studies of Weight decreased.

On Jul, 27, 2026

11 people who have Disseminated Tuberculosis and Weight Decreased are studied.

Would you have Weight decreased when you have Disseminated tuberculosis?

Gender of people who have Disseminated Tuberculosis and experienced Weight Decreased *:

female: 27.27 %
male: 72.73 %

Age of people who have Disseminated Tuberculosis and experienced Weight Decreased *:

Common co-existing conditions for these people *:

Pulmonary Tuberculosis (lungs tuberculosis): 3 people, 27.27%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 2 people, 18.18%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 18.18%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 9.09%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 9.09%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 9.09%
Joint Tuberculosis: 1 person, 9.09%
Hiv Infection: 1 person, 9.09%
Glomerulonephritis Proliferative (a disorder of the glomeruli (glomerulonephritis), or small blood vessels in the kidneys): 1 person, 9.09%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 9.09%

Common drugs taken by these people *:

Common symptoms for these people *:

Fever: 6 people, 54.55%
Pulmonary Tuberculosis (lungs tuberculosis): 4 people, 36.36%
Cough: 4 people, 36.36%
Hepatotoxicity (chemical-driven liver damage): 3 people, 27.27%
Weakness: 3 people, 27.27%
Depression: 2 people, 18.18%
Fatigue (feeling of tiredness): 2 people, 18.18%
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 2 people, 18.18%
Lymphopenia (an abnormally low level of lymphocytes in the blood): 2 people, 18.18%
Memory Loss: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Weight decreased?

- Check whether Weight decreased is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Disseminated tuberculosis (4,380 reports)
Weight decreased (364,522 reports)

All the drugs that are associated with Weight decreased:

Weight decreased (3,385 drugs)

All the conditions that are associated with Weight decreased:

Weight decreased (4,751 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Weight decreased and Disseminated tuberculosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.